Tolerance Bio is developing therapies to extend health span by preserving, restoring, and modulating thymic function - the master regulator of immune tolerance.

We are advancing a multi-modal, clinical-stage platform with multiple proof-of-concept readouts anticipated over the next 3–4 years.